As on Thursday, Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) started slowly as it slid -0.86% to $0.17, before settling in for the price of $0.17 at the close. Taking a more long-term approach, TNXP posted a 52-week range of $0.12-$22.14.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
In the past 5-years timespan, the Healthcare sector firm’s annual sales growth was 0.00%. Meanwhile, its Annual Earning per share during the time was 79.31%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 33.36%. This publicly-traded company’s shares outstanding now amounts to $186.89 million, simultaneously with a float of $186.89 million. The organization now has a market capitalization sitting at $32.24 million. At the time of writing, stock’s 50-day Moving Average stood at $0.1580, while the 200-day Moving Average is $3.0214.
Tonix Pharmaceuticals Holding Corp (TNXP) Ownership Facts and Figures
Another important factor to analyze is how key investors are playing towards the stock of the Biotechnology industry. Tonix Pharmaceuticals Holding Corp’s current insider ownership accounts for 0.00%, in contrast to 1.51% institutional ownership.
Tonix Pharmaceuticals Holding Corp (TNXP) Earnings and Revenue Records
Tonix Pharmaceuticals Holding Corp’s EPS increase for this current 12-month fiscal period is 33.36% and is forecasted to reach -14.11 in the upcoming year.
Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) Trading Performance Indicators
Let’s observe the current performance indicators for Tonix Pharmaceuticals Holding Corp (TNXP). It’s Quick Ratio in the last reported quarter now stands at 2.78. The Stock has managed to achieve an average true range (ATR) of 0.02. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 2.86.
In the same vein, TNXP’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -20.56, a figure that is expected to reach -3.90 in the next quarter, and analysts are predicting that it will be -14.11 at the market close of one year from today.
Technical Analysis of Tonix Pharmaceuticals Holding Corp (TNXP)
Through scrutinizing the latest numbers posted by the [Tonix Pharmaceuticals Holding Corp, TNXP], it can be observed that its last 5-days Average volume of 26.47 million was better the volume of 14.26 million, it posted the year before. During the previous 9 days, stock’s Stochastic %D was recorded 16.18% While, its Average True Range was 0.0225.
Raw Stochastic average of Tonix Pharmaceuticals Holding Corp (TNXP) in the period of the previous 100 days is set at 7.49%, which indicates a major fall in contrast to 30.75% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 120.45% that was higher than 113.88% volatility it exhibited in the past 100-days period.
